We serve Chemical Name:2-Bromo-N-butyl-5-fluorobenzamide CAS:951884-19-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-N-butyl-5-fluorobenzamide
CAS.NO:951884-19-8
Synonyms:PC7976;N-Butyl 2-bromo-5-fluorobenzamide
Molecular Formula:C11H13BrFNO
Molecular Weight:274.12900
HS Code:2924299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.10000
Exact Mass:273.01600
LogP:3.50900
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like PC7976 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Butyl 2-bromo-5-fluorobenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Butyl 2-bromo-5-fluorobenzamide Use and application,N-Butyl 2-bromo-5-fluorobenzamide technical grade,usp/ep/jp grade.
Related News: There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2-Bromo-N-butyl-5-fluorobenzamide manufacturer Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 2-Bromo-N-butyl-5-fluorobenzamide supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 2-Bromo-N-butyl-5-fluorobenzamide vendor There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2-Bromo-N-butyl-5-fluorobenzamide factory The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood.
